Respiratory Disease News

Medindia's Press Release’ section provides the latest press release on Respiratory Disease from across the world for the global audience. This page links to 906 Respiratory Disease press releases.

Toxic Thirdhand Smoke Residue Reaches Many Children Even in Nonsmoking Homes

PR Newswire CINCINNATI, June 6, 2025 More than 90% of all children tested showed evidence of exposure, with highest levels found among Black children and those living in low-income and low-education households CINCINNATI, June 6, 2025 ...


Trevi Therapeutics Announces Positive Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough

PR Newswire NEW HAVEN, Conn., June 2, 2025 Haduvio met the primary endpoint with statistically-significant reductions in 24-hour cough frequency across all dose groups (108 and 54 mg BID p Patients saw a rapid reduction in 24-hour cough ...

Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough

PR Newswire NEW HAVEN, Conn., June 1, 2025 Conference call and webcast to be held at 8:30 a.m. ET  NEW HAVEN, Conn., June 1, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company ...

Global tobacco experts issue stark warning that the world is on brink of turning into an 'ashtray planet' that will significantly escalate chronic respiratory diseases

PR Newswire COPENHAGEN, Denmark, May 30, 2025 COPENHAGEN, Denmark, May 30, 2025 /PRNewswire/ -- The Copenhagen Institute for Futures Studies (CIFS), an independent non-profit think tank, gathered twenty tobacco-control specialists from ...

ArkBio Announces Positive Phase II Results of AK3280 for Treatment of Idiopathic Pulmonary Fibrosis (IPF)

PR Newswire SHANGHAI, May 16, 2025 SHANGHAI, May 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of ...

CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH

PR Newswire NASHVILLE, Tenn. and CAMBRIDGE, England, May 13, 2025 Cumberland leveraging Qureight's deep-learning AI platform for its Phase II FIGHTING FIBROSIS™ clinical trial NASHVILLE, Tenn. and CAMBRIDGE, England, May 13, 2025 ...

Altesa BioSciences Details Positive Topline Vapendavir Results from Phase 2 Placebo-Controlled Rhinovirus Challenge Study in COPD Patients

PR Newswire COLLEGE PARK, Ga., May 7, 2025 Antiviral improved overall patient-reported measures of both upper, lower respiratory symptoms, shortened overall course of illness COLLEGE PARK, Ga., May 7, 2025 /PRNewswire/ -- Altesa ...

The AAAAI Stands for Patient Advocacy During National Asthma and Allergy Awareness Month

PR Newswire MILWAUKEE, May 6, 2025 Support Asthma and Allergy Awareness Month by Utilizing AAAAI Resources and Sharing Educational Materials MILWAUKEE, May 6, 2025 /PRNewswire-PRWeb/ -- The American Academy of Allergy, Asthma & ...

The Concentration of Nicotine in E-cigarettes Continues to Soar, Putting Young People at Higher Risk of Addiction

PR Newswire WASHINGTON, May 5, 2025 New Study Confirms That Many Disposable E-cigarettes Sold Today Come in Bigger Sizes and Are Cheaper Than Those Ever Sold Before WASHINGTON, May 5, 2025 /PRNewswire/ -- A new study published in the ...

New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis

PR Newswire BRIDGEWATER, N.J., April 23, 2025 —Largest Global Clinical Trial Ever Conducted in Bronchiectasis Demonstrates Statistically Significant and Clinically Meaningful Reduction in Frequency of Pulmonary Exacerbations Versus Placebo— ...

Respiratory Disease News »

Asthma Patients Throng Hyderabad for Annual ‘Fish Prasadam’ Ritual

Asthma Patients Throng Hyderabad for Annual ‘Fish Prasadam’ Ritual

Hundreds gather in Hyderabad for the annual ‘Fish Prasadam’ ritual, seeking relief from asthma through a traditional herbal remedy given with live fish.

Lungs on the Clock: Why Your Breathing Peak Ends by 25

Lungs on the Clock: Why Your Breathing Peak Ends by 25

Study finds lung capacity starts to decline between ages 20 and 25, highlighting the importance of early lung health monitoring and care.

Mucus Plugs in the Lungs Could Be Speeding Up COPD

Mucus Plugs in the Lungs Could Be Speeding Up COPD

Lung mucus plugs in COPD patients may drive faster disease progression and lung decline.

Sniffing Out the Flu: How a Supercharged Nasal Antibody Shields Against Viral Ambush

Sniffing Out the Flu: How a Supercharged Nasal Antibody Shields Against Viral Ambush

Scientists engineer a monoclonal antibody with strong binding ability, offering protection against influenza A in mice.

Could Screening for Both Active and Dormant TB Infections Improve Detection?

Could Screening for Both Active and Dormant TB Infections Improve Detection?

Screening for both active and dormant tuberculosis (TB) infections simultaneously could enhance detection and improve outcomes.

More Respiratory Disease News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement